Caricamento...
The challenge of modulating β-cell autoimmunity in type 1 diabetes
With the conceptual advance some four decades ago that type 1 diabetes (T1D) represents an autoimmune disease, hope emerged that immune-based therapies would quickly evolve as a means to prevent and reverse the disorder. However, despite dozens of clinical trials seeking to achieve that purpose, the...
Salvato in:
| Pubblicato in: | Lancet Diabetes Endocrinol |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7322790/ https://ncbi.nlm.nih.gov/pubmed/30528099 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2213-8587(18)30112-8 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|